0001209191-22-003268.txt : 20220114
0001209191-22-003268.hdr.sgml : 20220114
20220114090121
ACCESSION NUMBER: 0001209191-22-003268
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220113
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Piekos Brian
CENTRAL INDEX KEY: 0001815308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39438
FILM NUMBER: 22530534
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. /DE
CENTRAL INDEX KEY: 0001816736
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851613057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (617) 401-4400
MAIL ADDRESS:
STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: FS Development Corp.
DATE OF NAME CHANGE: 20200702
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-13
0
0001816736
Gemini Therapeutics, Inc. /DE
GMTX
0001815308
Piekos Brian
C/O GEMINI THERAPEUTICS, INC.
NOT APPLICABLE
DE
0
1
0
0
CFO
Restricted Stock Units
2022-01-13
4
A
0
280876
0.00
A
Common Stock
280876
280876
D
Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
These Restricted Stock Units shall vest on the one (1)-year anniversary of the date of grant.
/s/ Brian Piekos
2022-01-14